273 related articles for article (PubMed ID: 31819003)
1. Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin-mediated prostatic tumorigenesis.
Aldahl J; Mi J; Pineda A; Kim WK; Olson A; Hooker E; He Y; Yu EJ; Le V; Lee DH; Geradts J; Sun Z
J Biol Chem; 2020 Jan; 295(2):631-644. PubMed ID: 31819003
[TBL] [Abstract][Full Text] [Related]
2. Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis.
Lee SH; Luong R; Johnson DT; Cunha GR; Rivina L; Gonzalgo ML; Sun Z
Oncogene; 2016 Feb; 35(6):702-14. PubMed ID: 25893287
[TBL] [Abstract][Full Text] [Related]
3. Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and beta-catenin/Wnt pathways.
Previdi S; Maroni P; Matteucci E; Broggini M; Bendinelli P; Desiderio MA
Eur J Cancer; 2010 Jun; 46(9):1679-91. PubMed ID: 20350802
[TBL] [Abstract][Full Text] [Related]
4. Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.
Li X; Martinez-Ferrer M; Botta V; Uwamariya C; Banerjee J; Bhowmick NA
Oncogene; 2011 Jan; 30(2):167-77. PubMed ID: 20818421
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes.
Monga SP; Mars WM; Pediaditakis P; Bell A; Mulé K; Bowen WC; Wang X; Zarnegar R; Michalopoulos GK
Cancer Res; 2002 Apr; 62(7):2064-71. PubMed ID: 11929826
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of hepatocyte growth factor and its receptor, c-Met, during sex hormone-induced prostatic carcinogenesis in the Noble rat.
Tam NN; Chung SS; Lee DT; Wong YC
Carcinogenesis; 2000 Dec; 21(12):2183-91. PubMed ID: 11133807
[TBL] [Abstract][Full Text] [Related]
7. Expression array analysis of the hepatocyte growth factor invasive program.
Cecchi F; Lih CJ; Lee YH; Walsh W; Rabe DC; Williams PM; Bottaro DP
Clin Exp Metastasis; 2015 Oct; 32(7):659-76. PubMed ID: 26231668
[TBL] [Abstract][Full Text] [Related]
8. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice.
Apte U; Zeng G; Muller P; Tan X; Micsenyi A; Cieply B; Dai C; Liu Y; Kaestner KH; Monga SP
Hepatology; 2006 Oct; 44(4):992-1002. PubMed ID: 17006939
[TBL] [Abstract][Full Text] [Related]
9. HGF/SF modifies the interaction between its receptor c-Met, and the E-cadherin/catenin complex in prostate cancer cells.
Davies G; Jiang WG; Mason MD
Int J Mol Med; 2001 Apr; 7(4):385-8. PubMed ID: 11254878
[TBL] [Abstract][Full Text] [Related]
10. A novel rabbit anti-hepatocyte growth factor monoclonal neutralizing antibody inhibits tumor growth in prostate cancer cells and mouse xenografts.
Yu Y; Chen Y; Ding G; Wang M; Wu H; Xu L; Rui X; Zhang Z
Biochem Biophys Res Commun; 2015 Aug; 464(1):154-60. PubMed ID: 26093299
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte Growth Factor Modulates MET Receptor Tyrosine Kinase and β-Catenin Functional Interactions to Enhance Synapse Formation.
Xie Z; Eagleson KL; Wu HH; Levitt P
eNeuro; 2016; 3(4):. PubMed ID: 27595133
[TBL] [Abstract][Full Text] [Related]
12. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.
Bozkaya G; Korhan P; Cokaklı M; Erdal E; Sağol O; Karademir S; Korch C; Atabey N
Mol Cancer; 2012 Sep; 11():64. PubMed ID: 22962849
[TBL] [Abstract][Full Text] [Related]
13. Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma.
Li Y; Guessous F; Johnson EB; Eberhart CG; Li XN; Shu Q; Fan S; Lal B; Laterra J; Schiff D; Abounader R
Lab Invest; 2008 Feb; 88(2):98-111. PubMed ID: 18059365
[TBL] [Abstract][Full Text] [Related]
14. K-ras and Wnt signaling synergize to accelerate prostate tumorigenesis in the mouse.
Pearson HB; Phesse TJ; Clarke AR
Cancer Res; 2009 Jan; 69(1):94-101. PubMed ID: 19117991
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion.
Huang FI; Chen YL; Chang CN; Yuan RH; Jeng YM
Carcinogenesis; 2012 Jun; 33(6):1142-8. PubMed ID: 22436613
[TBL] [Abstract][Full Text] [Related]
16. Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling.
Lindner G; Menrad A; Gherardi E; Merlino G; Welker P; Handjiski B; Roloff B; Paus R
FASEB J; 2000 Feb; 14(2):319-32. PubMed ID: 10657988
[TBL] [Abstract][Full Text] [Related]
17. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
MacDougall CA; Vargas M; Soares CR; Holzer RG; Ide AE; Jorcyk CL
Prostate; 2005 Jul; 64(2):139-48. PubMed ID: 15678502
[TBL] [Abstract][Full Text] [Related]
18. The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression.
Verras M; Lee J; Xue H; Li TH; Wang Y; Sun Z
Cancer Res; 2007 Feb; 67(3):967-75. PubMed ID: 17283128
[TBL] [Abstract][Full Text] [Related]
19. Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells.
Tate A; Isotani S; Bradley MJ; Sikes RA; Davis R; Chung LW; Edlund M
BMC Cancer; 2006 Jul; 6():197. PubMed ID: 16869958
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
Humphrey PA; Zhu X; Zarnegar R; Swanson PE; Ratliff TL; Vollmer RT; Day ML
Am J Pathol; 1995 Aug; 147(2):386-96. PubMed ID: 7639332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
